Gefitinib (Cas: 184475-35-2)

Gefitinib (Cas: 184475-35-2)

Model No.︰API-Gefitinib

Brand Name︰Huavet

Country of Origin︰China

Unit Price︰-

Minimum Order︰1 gram

Inquire Now

Product Description

Product Name: Gefitinib (ZD1839)

CAS No.: 184475-35-2

Information: Selective EGFR inhibitor

Description: Gefitinib (ZD-1839) is an inhibitor of EGFR for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.

Other Names: Iressa;AKOS 91371; ZD 1839; Gefitinib(TINIBS)

Chemical Name: N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine

Canonical SMILES: COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4

MF: C22H24ClFN4O3

MW: 446.90236

Purity: 99.0% up by HPLC

Density: 1.322

Mol: 184475-35-2.mol

Appearance: White crystalline powder

Melting Point: 194.0~198.0°C

Water: ≤0.30%

Assay: 99.0% up by HPLC

Grade Standard: Medicine Grade

Type: Antineoplastic Agents

Solubility: Soluble in DMSO > 10 mM 

Storage: Store at -20°C 

General tips: For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 for several months. 

Shipping Condition: Evaluation sample solution : ship with blue ice. All other available size: ship with RT , or blue ice upon request

Background:Gefitinib, also known as ZD1839 or Iressa, is a potent and orally-bioavailable small-molecule inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase with 50% inhibition concentration IC50 values of 0.033 μM and 0.027 μM in A431 membrane prep and baculovirus lysate respectively. Gefitinib binds to the kinase ATP binding site of EGFR interfering with the binding of adenosine triphosphate, which suppresses the EGFR tyrosine kinase activity and resultant signal transduction of EGFR. Gefitinib exhibits anti-angiogenic activities in a wide range of human tumor types, including head and neck, prostate, breast, ovarian, colon, small-cell lung and non-small-cell lung cancer. Moreover, geftinib has also been found to reduce proliferation, induce cell cycle arrest and increase apoptosis.

Brand Name: Huavet

Place of Origin: Shaanxi, China (Mainland)

Usage: Pharmaceutical Intermediates

Inventory status: in stock

Shelf life: 2 years

Sample: Available

COA (Certificate of Analysis): Available

MSDS (Material Safety Data Sheet): Available

HPLC Spectrum: Available

ISO: Approved

GC: Available

NMR (Nuclear Magnetic Resonance): Available

Packaging Details:1g,5g,10g,50g,100g/bottle, 1kg/tin for trial order,25kg/drum for commercial quantity. Specific packing required by customer

Delivery Detail: Prompt shipment

 

Related Products

•Lapatinib

•Gefitinib hydrochloride

•AZD-9291

•AG-1478

•PD168393

•Icotinib Hydrochloride